ME 2303

ME 2303 (FAD 104) is a fluoro-pyranosyl adriamycin analogue with anti-tumor potential. ME 2303 can inhibit the proliferation of acute undifferentiated myeloblastic leukemia (AML) blast cells in a dose-dependent manner. ME 2303 can be used for the study of acute undifferentiated myeloblastic leukemia (AML) [1].

Product Specifications

CAS Number

[116521-53-0]

Product Name Alternative

FAD 104

UNSPSC

12352005

Target

Others

Related Pathways

Others

Field of Research

Cancer

Smiles

OC1=C2C([C@H](C[C@@](C(COC(CCCCCC(O)=O)=O)=O)(O)C2)O[C@@]3([H])[C@@H]([C@@H]([C@H](O)[C@H](C)O3)O)F)=C(O)C4=C1C(C5=CC=CC(OC)=C5C4=O)=O

Molecular Formula

C34H37FO15

Molecular Weight

704.65

References & Citations

[1]Blazsek I, et al. The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104) . Biomed Pharmacother. 1989;43 (4) :267-70.